Zobrazeno 1 - 10 of 149 pro vyhledávání: '"Martha P Mims"'
1
Akademický článek
Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma
Autor: Quillan Huang, Irene Mitsiades, Heidi Dowst, Neda Zarrin-Khameh, Attiya Batool Noor, Patricia Castro, Michael E. Scheurer, Guilherme Godoy, Martha P. Mims, Nicholas Mitsiades
Publikováno v: npj Precision Oncology, Vol 7, Iss 1, Pp 1-8 (2023)
Abstract The rising utilization of circulating tumor DNA (ctDNA) assays in Precision Oncology may incidentally detect genetic material from secondary sources. It is important that such findings are recognized and properly leveraged for both diagnosis
Externí odkaz: https://doaj.org/article/57fe4a7b16dc4018918af7f112ec4905
Zobrazit plný text záznamu
2
Data from Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt
Autor: Dov Kadmon, Michael M. Ittmann, Ming-Jer Tsai, J. Wade Harper, Thomas M. Wheeler, Brian J. Miles, Anna Frolov, R. Garret Lynch, Vivian MacDonnell, Teresa G. Hayes, Martha P. Mims, Timothy C. Thompson, Yi Ding, Rile Li, Jun Yan, Gustavo Ayala
Purpose: To assess the safety of administering bortezomib to patients undergoing a radical prostatectomy, to assess pathologic changes induced by bortezomib in prostate cancer specimen, and to verify alterations by the drug in proteasome protein targ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05441741c21215efc574ce5cc8976394
https://doi.org/10.1158/1078-0432.c.6516892.v1
Zobrazit plný text záznamu
4
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System
Autor: Courtney Nicole Miller-Chism, Harinder S. Juneja, Curtis Lachowiez, Hilary Y. Ma, Martha P. Mims, Wei Qiao, Onyebuchi Ononogbu, Mark M. Udden, Effrosyni Apostolidou
Publikováno v: Clin Lymphoma Myeloma Leuk
Despite therapeutic advances and improvement in outcomes of patients with acute lymphoblastic leukemia, as reported by specialized centers, healthcare disparities exist. This is a retrospective cohort analysis of the clinical outcomes of 146 patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9184d57e3366a83ef7248790274bf793
https://doi.org/10.1016/j.clml.2021.06.022
Zobrazit plný text záznamu
9
Abstract P2-10-11: Participation of African Americans in clinical trials supporting FDA approval of breast cancer medications
Autor: Courtney Nicole Miller-Chism, Rammurti T. Kamble, Samer Al Hadidi, Martha P. Mims
Publikováno v: Cancer Research. 80:P2-10
BACKGROUND African Americans comprise 12% of the total United States population. Lifetime probability of developing cancer in African Americans is 37.55%. Lifetime probability of developing breast cancer in African Americans is 11.1%. African America
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::693e4ca1c8d7546a9a1eb7ff1bd626a7
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-11
Zobrazit plný text záznamu
10
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer: Experience from a safety-net hospital serving a racially and ethnically diverse patient population
Autor: Alyssa Liang, Heidi Dowst, Neda Zarrin-Khameh, Quillan Huang, Attiya Batool Noor, Guilherme Godoy, Patricia Castro, Michael E. Scheurer, Susan G. Hilsenbeck, Martha P. Mims, Nicholas Mitsiades
Publikováno v: Journal of Clinical Oncology. 41:150-150
150 Background: Androgen deprivation therapy (ADT), CYP17 inhibitors (CYP17Is, e.g., abiraterone) and 2nd generation androgen receptor (AR) antagonists (2GARAs: enzalutamide, apalutamide, darolutamide) are important treatments for advanced prostate c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::268905a52281aac5271919f588155a3c
https://doi.org/10.1200/jco.2023.41.6_suppl.150
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje